Soma Gold Corp (SOMA.V) drills, mills, and produces gold in Colombia
Quimbaya Gold’s (QIM.C) CEO will buy his stock if you won’t
Salt, hydrogen, or uranium? Atco Mining (ATCO.C) hits all three
Prospera Energy (PEI.V) goes to borrowers again as boe/d drops 20%
Argo Living Soils (ARGO.C) creates carbon rich biochar.. could that be turned into graphene?
Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up 400% in a month
Core One Labs’ (COOL.C) wholly-owned subsidiary, Akome Biotech, has begun the development of a next-generation psychedelic drug formulation for the purpose of mitigating neurological damage that results from ischemic strokes. Read full article: https://equity.guru/2021/06/21/core-one-cool-c-subsidiary-begins-development-of-psychedelic-drug-formulation-for-stroke-treatment/
